Investors and Media
Press Releases
All Releases
View Summary ZIOPHARM Reports Third-Quarter 2014 Financial Results
Oct 30, 2014
PDF 13.5 KB Add to Briefcase
View Summary ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities
Aug 7, 2014
PDF 17.6 KB Add to Briefcase
View Summary ZIOPHARM Oncology and Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin
Jul 31, 2014
PDF 12.0 KB Add to Briefcase
View Summary ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and Clinical Program Update
Jul 22, 2014
PDF 15.5 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 18, 2014
PDF 6.6 KB Add to Briefcase
View Summary ZIOPHARM Announces Oral Presentation Highlighting Ad-RTS-IL-12 Results Correlated With Reducing Cancer Stem Cells in the Brain at ASGCT 17th Annual Meeting
May 22, 2014
PDF 11.0 KB Add to Briefcase
View Summary ZIOPHARM Reports First-Quarter 2014 Financial Results and Reviews Recent Activities
May 8, 2014
PDF 14.3 KB Add to Briefcase
View Summary ZIOPHARM Presents Preclinical Data at AACR Annual Meeting Supporting Controlled DNA-based IL-12 Therapy for Brain Cancer
Apr 8, 2014
PDF 10.6 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 21st Annual Future Leaders in the Biotech Industry Conference
Mar 20, 2014
PDF 6.6 KB Add to Briefcase
View Summary ZIOPHARM Reports Fourth-Quarter and Full-Year 2013 Financial Results and Reviews Recent Activities
Mar 3, 2014
PDF 16.4 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 16th Annual BIO CEO & Investor Conference
Feb 3, 2014
PDF 9.2 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 8, 2014
PDF 9.2 KB Add to Briefcase
View Summary ZIOPHARM Reports Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12
Dec 7, 2013
PDF 13.5 KB Add to Briefcase
View Summary ZIOPHARM Announces Unanimous Recombinant DNA Advisory Committee (RAC) Approval for Phase 1 Study of Ad-RTS-IL-12 in Subjects With Recurrent or Progressive Glioblastoma
Dec 6, 2013
PDF 11.4 KB Add to Briefcase
View Summary ZIOPHARM Oncology to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 27, 2013
PDF 9.1 KB Add to Briefcase
View Summary ZIOPHARM Oncology Prices Public Offering of Common Stock
Oct 24, 2013
PDF 10.0 KB Add to Briefcase
View Summary Mesoblast, Intrexon and ZIOPHARM to Target Cancers
Oct 23, 2013
PDF 15.2 KB Add to Briefcase
View Summary ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
Oct 22, 2013
PDF 10.0 KB Add to Briefcase
View Summary ZIOPHARM Announces Third Quarter Financial Results and Updates Key Development Activities
Oct 22, 2013
PDF 14.2 KB Add to Briefcase
View Summary ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Regulated Gene Expression System in Tumor-Homing Mesenchymal Stem Cells
Oct 22, 2013
PDF 51.0 KB Add to Briefcase
Showing 1-20 of 334 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase